Medical Condition

Understanding the potential link between infections and delirium offers a critical opportunity for improving care in elderly populations. Prompt identification and treatment of underlying causes can reduce morbidity and improve outcomes. Continued research into biomarkers, diagnostics, and immune-brain interactions will help refine strategies to protect cognitive health in vulnerable older adults.

Delirium in older adults often presents as an acute neuropsychiatric disturbance with a short time-course and a fluctuating pattern of attention, awareness, and cognition. It may include sudden disorientation, hallucinations, agitation, or marked lethargy. It is distinguished from dementia by its rapid onset and fluctuating course Dutta et al., 2022), and it is often reversible when the precipitating cause is identified and treated. Delirium is a clinical syndrome rather than a discrete diagnosis and reflects an underlying medical condition or physiologic stressor, including infection, metabolic derangements, or medication and toxin effects. (Inouye et al., 2014).

Prevalence for delirium is difficult to estimate in the general population as it is often under reported.  In general medical wards, the prevalence is between 15% to 25% and over 50% in postoperative or intensive care settings (Inouye et al., 2014).   The prevalence in long-term care facilities is unknown but assumed to be episodic and pervasive.

The association with infection is difficult to measure since the delirium is seldom recorded as an isolated code.  However, a prescription of antibiotics with no apparent precursor offers some clue.  Despite recommendations for more selective testing, many care facilities initiate antibiotics based solely on signs of delirium, reinforcing the presumed association with infection. Most patients (particularly one with any signs of dementia) will have at least one episode of antibiotics during a year.

Women appear to have a higher incidence of delirium (Rowe and Juthani-Mehta 2014), but this may be attributable to the higher baseline rate of UTIs rather than an inherent genetic vulnerability. Some genetic polymorphisms related to inflammatory cytokines and the APOE ε4 allele have been proposed as risk factors, though evidence remains inconclusive.

Secondary psychiatric manifestations are common and can overlap with, follow, or be mistaken for primary psychiatric disorders. These symptoms are typically acute, fluctuating, and reversible when the underlying infection is treated, but in some cases may persist or unmask underlying vulnerability.

Despite its prevalence, the underlying pathogenesis of delirium remains poorly understood. One hypothesis posits that systemic infections trigger autoantibodies or inflammatory mediators that cross a compromised blood-brain barrier, leading to transient disruption of neuronal function. Alternatively, direct neuroinflammation or microglial activation may alter neurotransmission and precipitate symptoms. The advanced age and frailty of affected patients often limit comprehensive diagnostic evaluation.

There is no definitive treatment for delirium itself. Clinical management focuses on identifying and addressing the underlying cause, which is often presumed to be infection. Supportive care, hydration, and medication review are essential components of treatment. Empiric antibiotics are frequently initiated when infection is suspected, particularly in long-term care settings.

The mechanisms linking infections such as UTIs to delirium likely involve systemic immune activation, disruption of blood-brain barrier integrity, and neuroinflammation. Infections can provoke the release of pro-inflammatory cytokines (e.g., IL-6, TNF-α) that either cross the BBB or activate CNS signaling through endothelial and glial pathways. This immune response may impair neurotransmitter balance, synaptic function, and neuronal connectivity. Older adults may be particularly vulnerable due to baseline neurodegeneration and age-related increases in BBB permeability. However, direct evidence for these mechanisms in human delirium remains limited.

Delirium in the elderly is common and frequently associated with infection, though causality remains uncertain. UTIs in this population are often treated empirically due to their perceived link with cognitive decline. Recognizing delirium as a manifestation of systemic illness rather than a discrete psychiatric condition is critical for effective management. Better diagnostic frameworks and mechanistic research are needed to disentangle association from causation.

Dujardin, K., et al. (2022). Infection, immune responses, and neuropsychiatric symptoms in the elderly. Neuroscience & Biobehavioral Reviews, 132, 456–470. https://doi.org/10.1016/j.neubiorev.2021.10.018

Dutta, C., et al. (2022). Urinary tract infection induced delirium in elderly patients: A systematic review. Cureus, 14(12), e32321. https://doi.org/10.7759/cureus.32321

Inouye, S. K., Westendorp, R. G. J., & Saczynski, J. S. (2014). Delirium in elderly people. The Lancet, 383(9920), 911–922. https://doi.org/10.1016/S0140-6736(13)60688-1

Rowe, T. A., & Juthani-Mehta, M. (2013). Urinary tract infection in older adults. Aging Health, 9(5), 519–528. https://doi.org/10.2217/ahe.13.49

Kalra, S., & Subramanian, S. (2011). Neuroinflammation and Alzheimer’s disease: The role of systemic infections. Journal of Neuroinflammation, 8, 112. https://doi.org/10.1186/1742-2094-8-112

Cunningham, C., Campion, S., Lunnon, K., et al. (2009). Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biological Psychiatry, 65(4), 304–312. https://doi.org/10.1016/j.biopsych.2008.07.024

Hughes, C., & Smith, M. (2007). Delirium and urinary tract infections: A misattribution in older adults? Age and Ageing, 36(6), 618–621. https://doi.org/10.1093/ageing/afm115

Tambyah, P. A., & Maki, D. G. (2000). Catheter-associated urinary tract infection is rarely symptomatic. Archives of Internal Medicine, 160(5), 678–682. https://doi.org/10.1001/archinte.160.5.678